Production (Stage)
Neural Therapeutics Inc.
NURL
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 963.74% | 619.05% | -58.34% | -76.71% | -92.10% |
| Total Receivables | 81.53% | -43.61% | 179.22% | -62.05% | -55.14% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 597.86% | 487.52% | -42.89% | -73.93% | -87.82% |
|
|
|||||
| Total Current Assets | 597.86% | 487.52% | -42.89% | -73.93% | -87.82% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 597.86% | 487.52% | -42.89% | -73.93% | -87.82% |
|
|
|||||
| Total Accounts Payable | -25.14% | -24.01% | 64.49% | -66.54% | -80.48% |
| Total Accrued Expenses | 21.71% | -32.22% | 26.05% | -25.68% | -74.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.19% | -27.42% | 38.55% | -38.37% | -76.55% |
|
|
|||||
| Total Current Liabilities | 7.19% | -27.42% | 38.55% | -38.37% | -76.55% |
| Long-Term Debt | 96.21% | 368.17% | 166.77% | 154.85% | 170.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 55.08% | 80.82% | 103.67% | 21.16% | -28.54% |
|
|
|||||
| Common Stock & APIC | 20.12% | -6.21% | -0.33% | 19.86% | 28.17% |
| Retained Earnings | -35.10% | -5.76% | -16.39% | -13.50% | -17.89% |
| Treasury Stock & Other | 155.17% | 88.66% | 19.22% | -42.52% | -22.16% |
| Total Common Equity | -9.70% | 3.90% | -200.38% | -148.37% | -20.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.70% | 3.90% | -200.38% | -148.37% | -20.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.70% | 3.90% | -200.38% | -148.37% | -20.51% |
|
|
|||||